Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 3/20 | 0.57 |
| ▸ | LDLR | P01130 | 1/20 | 0.43 |
| ▸ | PCSK9 | Q8NBP7 | 1/20 | 0.43 |
| ▸ | HTR2C | P28335 | 1/20 | 0.43 |
| ▸ | HPGDS | O60760 | 1/20 | 0.43 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.40 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.40 |
| ▸ | BRD4 | O60885 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.38 |
| ▸ | HTR6 | P50406 | 3/20 | 0.38 |
| ▸ | HTR2A | P28223 | 2/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | FNTA | P49354 | 1/20 | 0.37 |
| ▸ | FNTB | P49356 | 1/20 | 0.37 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19732321 | 0.88 | IDO1 (0.57) | IDO1LDLRPCSK9HTR2CHPGDS | |
| SCHEMBL20646497 | 0.88 | IDO1 (0.66) | IDO1LDLRPCSK9HTR2CHPGDS | |
| SCHEMBL21128503 | 0.82 | IDO1 (0.48) | IDO1LDLRPCSK9HTR2CHPGDS | |
| SCHEMBL19726602 | 0.76 | IDO1 (0.51) | IDO1LDLRPCSK9HTR2CHPGDS | |
| SCHEMBL19726613 | 0.76 | IDO1 (0.51) | IDO1LDLRPCSK9HTR2CHPGDS | |
| SCHEMBL21128561 | 0.76 | IDO1 (0.44) | IDO1LDLRPCSK9HTR2CHPGDS | |
| SCHEMBL3710027 | 0.73 | HTR2C (0.61) | IDO1LDLRPCSK9HTR2CHPGDS | |
| SCHEMBL31326499 | 0.73 | IDO1 (1.00) | IDO1LDLRPCSK9HTR2CHPGDS | |
| SCHEMBL21128380 | 0.70 | CYP17A1 (0.50) | CYP11B1CYP11B2CYP3A4CYP1A2CYP2D6 | |
| SCHEMBL9701669 | 0.70 | TSHR (0.45) | IDO1BRD4CYP3A4CYP1A2CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11233205-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2022-01-25 | — | — | US | disclosed |
| US-20190189939-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION | 2019-06-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190189939-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD1, OCIAD2, OSTC | IDO1 2470/4885LDLR 1227/4885PCSK9 3790/4885 |
| US-11233205-B2 | Organic electroluminescent materials and devices | OCIAD1, OCIAD2, OSTC | IDO1 2470/4885LDLR 1227/4885PCSK9 3790/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.